期刊文献+

穿膜序列对MHC-Ⅰ类限制性CTL表位呈递影响的研究 被引量:3

Effect of cell-penetrating peptides on MHC class Ⅰ restricted CTL epitope presentation
下载PDF
导出
摘要 目的 :从时间依赖性抗原呈递动力学的角度研究穿膜序列 (CPP)对 MHC- 类限制性 CTL 表位呈递的影响。 方法 :应用多肽固相合成技术 ,分别合成含 CPP与 H- 2 Kb限制性 CTL 表位 OVA2 57- 2 6 4的融合多肽 ,同时合成该表位 N、C端自然延伸的抗原肽和无关对照肽。采用流式细胞仪 (FACS)分析技术 ,检测抗原呈递细胞 (APC)在不同时相点对上述各抗原肽进行 MHC- 类呈递的情况。结果 :与不含 CPP的抗原肽相比 ,含 CPP的抗原肽中的 CTL 表位更易进入 APC内 MHC- 类呈递途径 ,表现为呈递所需时间明显缩短 (P<0 .0 5 ) ,且同一时相点的呈递强度显著增加 (P<0 .0 5 )。 结论 :在外源性抗原肽中引入穿膜序列可明显促进其 MHC- 类限制性 CTL 表位的呈递效率 。 Objective:To explain the effect of cell penetrating peptides (CPP) on enhancing the immunogenicity of exogenous antigenic peptides through kinetic analysis of time dependent MHC class Ⅰ antigen presentation.Methods:Peptides containing CPP and an H 2K b restricted CTL epitope OVA 257 264 were synthesized by standard solid phase Fmoc chemistry.An N and C terminal extended epitope and an irrelated peptide were used as control.Time dependent kinetics of MHC class Ⅰ antigen presentation was detected by APC fed with these peptides using flow cytometer analysis.Results:Antigenic peptides containing CPP were presented much more effectively by MHC class Ⅰmolecules than those without CPP.Conclusion:CPP can effectively enhance the immunogenicity of exogenous antigenic peptides by promoting MHC class Ⅰ antigen presentation.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第10期1106-1108,共3页 Academic Journal of Second Military Medical University
基金 国家 973计划资助项目 (2 0 0 1CB5 10 0 0 1) 国家自然科学基金资助项目 (3 980 0 170 )
关键词 穿膜序列 MHC-I类 限制性CTL 抗原呈递 动力学分析 肿瘤 免疫疗法 cell penetrating peptides(CPP) CTL epitope MHC class Ⅰ antigen presentation kinetic analysis
  • 相关文献

参考文献2

二级参考文献30

  • 1[1]Joliot A, Pernelle C, Deagostini Bazin H, et al. Antennapedia homeobox peptide regulates neural morphogenesis [J]. Proc Natl Acad Sci USA, 1991,88(5): 1 864- 1 868.
  • 2[2]Schwarze SR, Ho A, Vocero Akbani A, et al. In vivo protein transduction: delivery of a biologically active protein into the mouse [J] .Science,1999,285(5 433): 1 569- 1 572.
  • 3[3]Schwarze SR, Dowdy SF. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA[J].Trends Pharmacol Sci, 2000, 21(2): 45-48.
  • 4[4]Derossi D, Joliot AH, Chnssaing G, et al.The third helix of the Antennapedia homeodomain translocates through biological membranes[J]. J Biol Chem, 1994,269(14): 10 444-10 450.
  • 5[5]Elliott G, O' Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein [J]. Cell, 1997,88(2): 223 - 233.
  • 6[6]Phelan A, Elliott G, O' Hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22 [J]. Nat Biotechnol, 1998,16(5): 440 - 443.
  • 7[7]Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells[ J ]. Proc Natl Aead Sci USA,1994, 91(2): 664 - 668.
  • 8[8]Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus[J]. J Biol Chem,1997,272(25): 16 010- 16 017.
  • 9[9]Nagahara H, Vocero Akbani AM, Snyder EL, et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kipl induces cell migration [J]. Nat Med,1998,4(12):1 449-1 445.
  • 10[10]Brodsky JL. Translocation of proteins across the endoplasmic reticulum membrane[J]. Int Rev Cytol, 1998, 178:277 -328.

共引文献2

同被引文献23

  • 1王莉,吴玉章.穿膜肽研究展望[J].免疫学杂志,2001,17(z1):12-16. 被引量:2
  • 2Chen Y, J Sidney, S Southwood, et al. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-2.1 with high affinity and in different conformations[J]. J Immunol, 1994,152:2874-2881.
  • 3Colson YL,Tripp RA,Doherty PC,et al. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras:functional restriction to host MHC[J]. J Immunol.,1998, 160:3790-3796.
  • 4Colonna M. Natural killer cell receptors specific for MHC class Ⅰ molecules[J]. Curr Opin Immunol.,1996, 8(1):101-107.
  • 5Smith CV,Rosengard BR,Guzzete PC,et al. Approaches to transplantation tolerance[J]. Transplant Proc,1991,23:2157-2161.
  • 6Nienhuis AW,McDonagh KT,Bodine DM. Gene transfer into hematopoietic stem cells[J]. Cancer,1991,67:2700-2704.
  • 7Petersz GA , Li W, Apostolopoulos V. A 16-mer peptide(RQIKIWFQNRRMKWKK)from antennapedia preferentially targets the class I pathway[J]. Vaccine,2001, 19(11-12):1397-1405.
  • 8Porgador A, Yewdell JW, Deng Y, et al. Localization,quantitation, and in situ detection of specific peptide-MHC class Ⅰ complexes using a monoclonal antibody [ J ]. Immunity, 1997, 6 (6) : 715- 726.
  • 9Saric T, Beninga J, Graef CI, et al. Major histocompatibility complex class Ⅰ-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase [J]. J Biol Chem, 2001, 276 (39) : 36 474 - 36 481.
  • 10Schwarz K, de Giuli R, Schmidtke G, et al. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses [J]. J Immunol, 2000, 164 (12): 6 147-6 157.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部